Biotechnology News

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

November 5, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. Reports Third Quarter 2012 Financial Results

November 5, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights. “The highlights of this...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the following...

November 5, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX) - a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology and diagnostic applications - expects to release its third quarter 2012 results...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced that more than 60 abstracts from studies involving five molecules in the Company’s...

November 5, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that more than a dozen abstracts, in addition to several collaborator abstracts, for both ADCETRIS (brentuximab vedotin) and investigational antibody-drug...

November 5, 2012

BOSTON--(BUSINESS WIRE)--Goodwin Procter LLP has been named as the 2013 U.S. News-Best Lawyers’ “Law Firm of the Year” in Biotechnology Law.

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics Completes $13 Million Series B Financing; Announces Leadership Changes

November 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only New findings presented at the 2012 American Heart Association Scientific Sessions in Los Angeles provide early indications that a highly specific and selective...

November 5, 2012

GLASGOW, Scotland--(BUSINESS WIRE)--A new Open Innovation forum for researchers to access Virttu's modified oncolytic virus for new combination therapy trials

November 5, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Data presented at the American Heart Association meeting confirmed that the St. Jude Medical EnligHTN renal denervation system had a safe, effective and sustained blood pressure reduction at 6 months.

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--UpToDate hosted a series of forums with physicians in Mexico last week to discuss the power of clinical decision support (CDS) systems in improving patient care.

November 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Following independent regulatory appraisals of the safety and efficacy of the anticoagulation therapy Pradaxa®, both the U.S. Food and Drug Administration (FDA...

November 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced preliminary clinical findings from an ongoing open-label Phase 2 study demonstrating the safety and efficacy of FG-4592, investigational oral hypoxia-inducible factor (HIF) prolyl...

November 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the prostate cancer drug market will more than double, increasing from $4.1...

November 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced that data from an ongoing Phase 2 study of FG-4592, an orally delivered, small molecule treatment for anemia, were presented on 2 November 2012, at the American Society of Nephrology...

November 5, 2012

TORONTO--(BUSINESS WIRE)--New healthcare scrub rental machine eliminates scrub shortages while improving infection control efforts.

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that data from its ongoing Phase 1 trial of IPI-145, the company’s potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma...

November 5, 2012

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the U.S. Patent Office issued Patent # 8,298,560 “Methods and...

November 5, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced management changes to its executive leadership team. Mr. Allan Oberman, Senior Vice President of North America Generic Pharmaceuticals of Teva, has been...

November 5, 2012

TOKYO--(BUSINESS WIRE)--On Wednesday October 24, 2012, the Ornithine Laboratory has made a new video available to the public on its website for the 'Japan Otsukare University, Faculty of Ornithine' (literally University of Fatigue, Faculty of...

November 5, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCor Medical reports 100% responder rate at one-year follow-up in clinical trial of ultrasound-based PARADISE™renal denervation system for treating resistant hypertension

November 5, 2012

SHREVEPORT, La.--(BUSINESS WIRE)--A new interview with Dr. Lane Rosen explores why the Willis-Knighton Cancer Center in Shreveport, La., sought to add proton therapy to its cancer care options.

November 5, 2012

LAFAYETTE HILL, Pa.--(BUSINESS WIRE)--IPS-Integrated Project Services, a leading, full-service engineering, construction, commissioning and qualification firm dedicated to helping clients succeed with capital projects and improve operations,...

November 5, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”, OTCBB: ACTC or the “Company”), a leader in the field of regenerative medicine announced today that it will release its third quarter 2012 financial results on Thursday,...

November 5, 2012

DURHAM, North Carolina--(BUSINESS WIRE)--Doe & Ingalls, a part of Thermo Fisher Scientific and premium provider of specialty production chemicals and customized supply-chain services to the life sciences and microelectronics industries,...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company today announced it has been named the best large company to work for in metropolitan Boston by the Boston Globe. This year, Millennium ranked first among large companies,...

November 5, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Lee R. McCracken has been appointed Chief Executive Officer of Pathwork Diagnostics, Inc., the innovator of the Pathwork® Tissue of Origin Test.

November 5, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced the U.S. Centers for Medicare & Medicaid Services (...

November 5, 2012

SAN DIEGO & SAN FRANCISCO--(BUSINESS WIRE)--BioNano Genomics announces its breakthrough Irys genome mapping system, empowering genomics researchers with a new way of achieving more accurate and comprehensive discoveries.

November 5, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today announced the presentation of key findings related to lipoprotein particles (LDL-P) and cardiovascular disease at the Annual Meeting of the American Heart Association (AHA).

November 5, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) has ranked first among U.S. healthcare companies in Newsweek magazine’s Green Rankings for the fourth time since the list’s inception in 2009. Baxter has also been named the...

November 5, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups and health systems, today announced...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa to present at BIO-Europe 2012, and participate in panel on companion diagnostics.

November 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist has been named one of the Top Places to Work in Massachusetts in an annual employee-based survey from The Boston Globe. Cubist has been named to the list for five consecutive years.

November 5, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today announced that it has received a Notice of Allowance of a U.S. patent for the use of Thymosin beta 4 (Tβ4), certain...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer announced the launch of a panel of nine new epigenetic research assay kits for the detection of endogenous histone modifications.

November 5, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

November 5, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today reported financial results for the quarter ended September 30, 2012 and highlighted recent corporate progress.

November 5, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Core research facilities on the Science Exchange network announced today their support for those researchers affected by Hurricane Sandy.

November 5, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics today announced that the Food and Drug Administration (FDA) has accepted Sunovion’s IND for SEP360, triggering a milestone payment to PsychoGenics, and that human dosing has been initiated. In August...

November 5, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO) announced that Eileen Schloss, a human resources and business administration executive with more than 25 years of experience and executive leadership, has been named executive vice...

November 5, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Jefferies 2012 Global Healthcare Conference on Thursday, November 15 at 3:00 p.m. (GMT) / 10:00 a.m. (EST) in London. The presentation will...

November 5, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--FDA designated Durata Therapeutics' dalbavancin as a QIDP, conferring priority review, eligibility for fast-track status, & 5 years additional statutory exclusivity following FDA approval for ABSSSI.

November 5, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks has been fully National Center for Quality Assurance (NCQA) certified as a CAHPS® Patient-Centered Medical Home (PCMH) Survey Vendor to conduct NCQA HEDIS® Surveys.

November 5, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics announces upcoming data presentations at the Society of Neuro-Oncology’s 17th Annual Scientific Meeting and Education Day on Thursday, November 15, 2012.